IR@PKUHSC  > 北京大学公共卫生学院
学科主题公共卫生
Predictors of Visual Response to Intravitreal Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Fang, Kai1; Tian, Jun1; Qing, Xueying1; Li, Shuai1; Hou, Jing2,3; Li, Juan4; Yu, Wenzhen2,3; Chen, Dafang1; Hu, Yonghua1; Li, Xiaoxin2,3
刊名JOURNAL OF OPHTHALMOLOGY
2013
DOI10.1155/2013/676049
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, Research & Experimental ; Ophthalmology
资助者Ministry of Science and Technology of the People&prime ; s Republic of China, Beijing, China ; Ministry of Science and Technology of the People&prime ; s Republic of China, Beijing, China
研究领域[WOS]Research & Experimental Medicine ; Ophthalmology
关键词[WOS]ENDOTHELIAL GROWTH-FACTOR ; CHOROIDAL NEOVASCULARIZATION ; CIGARETTE-SMOKING ; RANIBIZUMAB TREATMENT ; SUBGROUP ANALYSIS ; EPITHELIAL-CELLS ; RISK-FACTORS ; FACTOR VEGF ; ASSOCIATION ; EXPRESSION
英文摘要

Purpose. To identify the predictors of visual response to the bevacizumab treatment of neovascular age-related macular degeneration (AMD). Design. A cohort study within the Neovascular AMD Treatment Trial Using Bevacizumab (NATTB). Methods. This was a multicenter trial including 144 participants from the NATTB study. Visual outcomes measured by change in visual acuity (VA) score, proportion gaining >= 15 letters, and change in central retinal thickness (CRT) were compared among groups according to the baseline, demographic, and ocular characteristics and genotypes. Results. Mean change in the VA score was 9.2 +/- 2.3 SD letters with a total of 46 participants (31.9%) gaining >= 15 letters. Change in median CRT was -81.5 mu m. Younger age, lower baseline VA score, shorter duration of neovascular AMD, and TT genotype in rs10490924 were significantly associated with greater VA score improvement (P = 0.028, P < 0.001, P = 0.02, and P = 0.039, resp.). Lower baseline VA score and TT genotype in rs10490924 were significantly associated with a higher likelihood of gaining >= 15 letters (P = 0.028, and P = 0.021, resp.). Conclusions. Baseline VA and genotype of rs10490924 were both important predictors for visual response to bevacizumab at 6 months. This trial is registered with the Registration no. NCT01306591.

语种英语
所属项目编号2006BAI02B05
资助者Ministry of Science and Technology of the People&prime ; s Republic of China, Beijing, China ; Ministry of Science and Technology of the People&prime ; s Republic of China, Beijing, China
WOS记录号WOS:000324200500001
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63195
专题北京大学公共卫生学院
作者单位1.Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100191, Peoples R China
2.Peking Univ, Dept Ophthalmol, Peoples Hosp, Beijing 100044, Peoples R China
3.Minist Educ, Key Lab Vis Loss & Restorat, Beijing 100044, Peoples R China
4.Beijing Ctr Dis Control & Prevent, Inst Immunoprophylaxis, Beijing 100013, Peoples R China
推荐引用方式
GB/T 7714
Fang, Kai,Tian, Jun,Qing, Xueying,et al. Predictors of Visual Response to Intravitreal Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration[J]. JOURNAL OF OPHTHALMOLOGY,2013.
APA Fang, Kai.,Tian, Jun.,Qing, Xueying.,Li, Shuai.,Hou, Jing.,...&Li, Xiaoxin.(2013).Predictors of Visual Response to Intravitreal Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration.JOURNAL OF OPHTHALMOLOGY.
MLA Fang, Kai,et al."Predictors of Visual Response to Intravitreal Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration".JOURNAL OF OPHTHALMOLOGY (2013).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Fang, Kai]的文章
[Tian, Jun]的文章
[Qing, Xueying]的文章
百度学术
百度学术中相似的文章
[Fang, Kai]的文章
[Tian, Jun]的文章
[Qing, Xueying]的文章
必应学术
必应学术中相似的文章
[Fang, Kai]的文章
[Tian, Jun]的文章
[Qing, Xueying]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。